327 related articles for article (PubMed ID: 23280545)
1. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study.
Kashani L; Raisi F; Saroukhani S; Sohrabi H; Modabbernia A; Nasehi AA; Jamshidi A; Ashrafi M; Mansouri P; Ghaeli P; Akhondzadeh S
Hum Psychopharmacol; 2013 Jan; 28(1):54-60. PubMed ID: 23280545
[TBL] [Abstract][Full Text] [Related]
2. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial.
Modabbernia A; Sohrabi H; Nasehi AA; Raisi F; Saroukhani S; Jamshidi A; Tabrizi M; Ashrafi M; Akhondzadeh S
Psychopharmacology (Berl); 2012 Oct; 223(4):381-8. PubMed ID: 22552758
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial.
Khazaie H; Rezaie L; Rezaei Payam N; Najafi F
Gen Hosp Psychiatry; 2015; 37(1):40-5. PubMed ID: 25467077
[TBL] [Abstract][Full Text] [Related]
4. Effect of vitamin E with and without saffron on the sexual function in women of reproductive age with sexual dysfunction: a randomized controlled trial.
Izadi S; Mohammad-Alizadeh-Charandabi S; Yadollahi P; Mirghafourvand M
BMC Womens Health; 2024 Feb; 24(1):143. PubMed ID: 38408971
[TBL] [Abstract][Full Text] [Related]
5. Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.
Talaei A; Hassanpour Moghadam M; Sajadi Tabassi SA; Mohajeri SA
J Affect Disord; 2015 Mar; 174():51-6. PubMed ID: 25484177
[TBL] [Abstract][Full Text] [Related]
6. A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression.
Akhondzadeh S; Mostafavi SA; Keshavarz SA; Mohammadi MR; Hosseini S; Eshraghian MR
J Clin Pharm Ther; 2020 Feb; 45(1):134-143. PubMed ID: 31602695
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial.
Kashani L; Esalatmanesh S; Eftekhari F; Salimi S; Foroughifar T; Etesam F; Safiaghdam H; Moazen-Zadeh E; Akhondzadeh S
Arch Gynecol Obstet; 2018 Mar; 297(3):717-724. PubMed ID: 29332222
[TBL] [Abstract][Full Text] [Related]
8. Study the effects of saffron on depression and lipid profiles: A double blind comparative study.
Sahraian A; Jelodar S; Javid Z; Mowla A; Ahmadzadeh L
Asian J Psychiatr; 2016 Aug; 22():174-6. PubMed ID: 26611571
[TBL] [Abstract][Full Text] [Related]
9. Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study.
Akhtari E; Raisi F; Keshavarz M; Hosseini H; Sohrabvand F; Bioos S; Kamalinejad M; Ghobadi A
Daru; 2014 Apr; 22(1):40. PubMed ID: 24773615
[TBL] [Abstract][Full Text] [Related]
10. Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders-a double-blind, randomized intervention study.
Ahmadpanah M; Ramezanshams F; Ghaleiha A; Akhondzadeh S; Sadeghi Bahmani D; Brand S
Psychiatry Res; 2019 Dec; 282():112613. PubMed ID: 31669837
[TBL] [Abstract][Full Text] [Related]
11.
Kashani L; Aslzadeh S; Shokraee K; Shamabadi A; Tadayon Najafabadi B; Jafarinia M; Esalatmanesh S; Akhondzadeh S
Avicenna J Phytomed; 2022; 12(3):257-268. PubMed ID: 36186931
[TBL] [Abstract][Full Text] [Related]
12. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
Noorbala AA; Akhondzadeh S; Tahmacebi-Pour N; Jamshidi AH
J Ethnopharmacol; 2005 Feb; 97(2):281-4. PubMed ID: 15707766
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial.
Kashani L; Eslatmanesh S; Saedi N; Niroomand N; Ebrahimi M; Hosseinian M; Foroughifar T; Salimi S; Akhondzadeh S
Pharmacopsychiatry; 2017 Mar; 50(2):64-68. PubMed ID: 27595298
[No Abstract] [Full Text] [Related]
14. Changes in sexual function during acute and six-month fluoxetine therapy: a prospective assessment.
Michelson D; Schmidt M; Lee J; Tepner R
J Sex Marital Ther; 2001; 27(3):289-302. PubMed ID: 11354934
[TBL] [Abstract][Full Text] [Related]
15. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
Ahrold TK; Meston CM
J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
[TBL] [Abstract][Full Text] [Related]
16. The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study.
Madeo B; Bettica P; Milleri S; Balestrieri A; Granata AR; Carani C; Rochira V
J Sex Med; 2008 Oct; 5(10):2431-41. PubMed ID: 18410297
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
Coleman CC; King BR; Bolden-Watson C; Book MJ; Segraves RT; Richard N; Ascher J; Batey S; Jamerson B; Metz A
Clin Ther; 2001 Jul; 23(7):1040-58. PubMed ID: 11519769
[TBL] [Abstract][Full Text] [Related]
18. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study.
Safarinejad MR
BJU Int; 2010 Sep; 106(6):840-7. PubMed ID: 20067456
[TBL] [Abstract][Full Text] [Related]
19. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.
Safarinejad MR
J Psychopharmacol; 2011 Mar; 25(3):370-8. PubMed ID: 20080928
[TBL] [Abstract][Full Text] [Related]
20. Effect of l-arginine compared to placebo on sexual function in women with major depressive disorder: a randomized controlled trial.
Torkaman P; Meybodi AM; Kheradmand A; Eiliaei S; Ardakani MT
BMC Psychiatry; 2024 May; 24(1):358. PubMed ID: 38745327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
